AMENDED AND RESTATED EMPLOYMENT APPORTIONMENT AGREEMENTEmployment Apportionment Agreement • August 2nd, 2023 • BeiGene, Ltd. • Pharmaceutical preparations • Beijing
This Amended and Restated Employment Apportionment Agreement (this “Agreement”) is made and entered into by and among BeiGene (Beijing) Co., Limited (the “Company”), BeiGene Guangzhou Biologics Manufacturing Co., Ltd. (the “GZ Co.”), BeiGene Pharmaceutical (Shanghai) Co., Ltd. (the “SH Co.”) and Dr. Wu Xiaobin (the “Executive”), on June 16, 2023 and effective as of June 1, 2023 (the “Effective Date”). Capitalized terms used but not defined in this Agreement shall have the meanings assigned to them in the Executive Employment Agreement entered into by and between the Company and the Executive, effective as of April 30, 2018 (the “Employment Agreement”).
EMPLOYMENT APPORTIONMENT AGREEMENTEmployment Apportionment Agreement • May 11th, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • Beijing
This Employment Apportionment Agreement (this “Agreement”) is made and entered into by and among BeiGene (Beijing) Co., Limited (the “Company”), BeiGene Guangzhou Biologics Manufacturing Co., Ltd. (the “GZ Co.”), and Dr. Wu Xiaobin (the “Executive”), on March 1, 2020 (the “Effective Date”). Capitalized terms used but not defined in this Agreement shall have the meanings assigned to them in the Executive Employment Agreement entered into by and between the Company and the Executive, effective as of April 30, 2018 (the “Employment Agreement”).
